The Use of ADV6209 for Premedication in Pediatric Anesthesia
A recently posted phase 2 clinical trial (not yet recruiting) aims to evaluate the effect of ADV6209, a new oral
Category: Pharma applications
Axsome Therapeutics Announces Acceleration of MOMENTUM Phase 3 Trial of AXS-07 in Migraine
Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today
Cyclodextrins as possible antidotes to box jellyfish venom
Box jellyfish (Chironex fleckeri) found in coastal waters from northern Australia and New Guinea north to the Philippines and Vietnam
Enrollment completed of Phase 1 Clinical Trial of Captisol-enabled Iohexol
Ligand Pharmaceuticals Incorporated announced completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol
Special issue: Nanoconstructs Based on Cyclodextrins
A special issue in Nanomaterials, an open access journal of MDPI will focus on native or modified CDs leading to
New book: Nanosponges: Synthesis and Applications
Wiley has recently published a book on nanosponges edited by Francesco Trotta and Andrea Mele. The book gives an excellent
Rabbits in cyclodextrin research
Rabbits are small animals, favorite models in pharmaceutical research. In Scopus search 554 hits were found for the keywords: “cyclodextrin
Making Pharmaceuticals EXHIBITION & CONFERENCE
The Leading UK Pharmaceutical Exhibition and Conference will be held on 30 April –1 May Ricoh Arena, Coventry, UK. The
Host-guest chemistry for the treatment of leishmania
Human leishmaniasis is an infectious parasitic disease endemic to about 90 countries by over 20 different Leishmaniasis species. It is
CycloMolder software
The CycloMolder software consists of two modules: CycloGen and CycloDock. The first module builds theoretical models to represent a cyclodextrin